CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Association of Cardiovascular Disease With Respiratory Disease Dapagliflozin for treating chronic heart failure with reduced ejection fraction AIM2-driven inflammasome activation in heart failure A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics.

Original Research2020 Jul 18.

JOURNAL:ESC Heart Fail. Article Link

Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure

HC Chang, CJ Huang, HM Cheng et al. Keywords: acute heart failure; nighttime haemodynamics; nocturnal thoracic volume overload; post-discharge outcomes

Full Text PDF